Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Fluoresc ; 2023 Aug 25.
Artigo em Inglês | MEDLINE | ID: mdl-37624469

RESUMO

A known property of quantum dots (QDs) is their characteristic luminescence, which would make it possible to detect different types of cancers after being functionalized with some type of biological molecule. For this reason, in the present investigation a methodological analysis of the physicochemical characteristics of the CdTe/ZnS core/shell QDs was carried out, using techniques such as Optical Absorbance Spectroscopy (UV-Vis), Molecular Fluorescence, Fourier Transform Infrared Spectroscopy (FT-IR), Dynamic Light Scattering (DLS), X-Ray Diffraction (XRD), Transmission Electron Microscopy (TEM) and Zeta Potential that allowed to verify the photoluminescent effectiveness of these semiconductor nanocrystals as an alternative to conventional techniques currently used for the detection of specific cancers smaller than 1 cm. The study consisted of theoretically determining the bandgap energy, the size of the nanocrystals and the molar absorptivity from the wavelength value for the maximum intensity of the excitonic peak. It was also possible to verify the maximum intensity for each sample and thus evaluate its photoluminescent response, as well as it was possible to determine the charge distribution, the hydrodynamic size and the surface composition of each quantum dot. The results obtained correspond to what has been reported in the literature, which makes them good candidates for the detection of cancer in precancerous stages.

2.
Respiration ; 101(1): 1-15, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-34814151

RESUMO

Rates of antimicrobial resistance are increasing globally while the pipeline of new antibiotics is drying up, putting patients with disease caused by drug-resistant bacteria at increased risk of complications and death. The growing costs for diagnosis and management of drug resistance threaten tuberculosis control where the disease is endemic and resources limited. Bacteriophages are viruses that attack bacteria. Phage preparations served as anti-infective agents long before antibiotics were discovered. Though small in size, phages are the most abundant and diverse biological entity on earth. Phages have co-evolved with their hosts and possess all the tools needed to infect and kill bacteria, independent of drug resistance. Modern biotechnology has improved our understanding of the biology of phages and their possible uses. Phage preparations are available to treat meat, fruit, vegetables, and dairy products against parasites or to prevent contamination with human pathogens, such as Listeria monocytogenes, Escherichia coli, or Staphylococcus aureus. Such phage-treated products are considered fit for human consumption. A number of recent case reports describe in great detail the successful treatment of highly drug-resistant infections with individualized phage preparations. Formal clinical trials with standardized products are slowly emerging. With its highly conserved genome and relative paucity of natural phage defence mechanisms Mycobacterium tuberculosis appears to be a suitable target for phage treatment. A phage cocktail with diverse and strictly lytic phages that kill all lineages of M. tuberculosis, and can be propagated on Mycobacterium smegmatis, has been assembled and is available for the evaluation of optimal dosage and suitable routes of administration for tuberculosis in humans. Phage treatment can be expected to be safe and active on extracellular organisms, but phage penetration to intracellular and granulomatous environments as well as synergistic effects with antibiotics are important questions to address during further evaluation.


Assuntos
Bacteriófagos , Micobacteriófagos , Mycobacterium tuberculosis , Tuberculose , Antibacterianos , Delusões , Humanos , Micobacteriófagos/genética , Tuberculose/tratamento farmacológico
4.
Biol Reprod ; 71(3): 790-6, 2004 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-15128594

RESUMO

Follicular atresia is believed to be largely regulated by apoptosis. To further understand how apoptosis can affect cumulus cells and oocytes we have evaluated the incidence and regulation of apoptosis affecting bovine cumulus oocyte complexes in vitro. Expression of components of the Fas signaling pathway was studied in both oocytes and cumulus cells by polymerase chain reaction after reverse transcription, immunoblotting, and indirect immunofluorescence. Furthermore, the Fas signaling pathway was activated in cumulus oocyte complexes with an agonistic anti-Fas antibody during in vitro maturation in the presence or absence of FSH. Viability and incidence of apoptosis in cumulus cells were evaluated by assessing membrane integrity and nuclear morphology. Oocyte nuclear maturation was also analyzed, as well as cleavage rates, blastocyst formation rates, and blastocyst quality, following in vitro fertilization. Fas mRNA and protein were expressed both in oocytes and cumulus cells. FasL protein was found in cumulus cells but could not be detected in oocytes, despite its mRNA expression. Both activation of the Fas pathway and presence of FSH during in vitro maturation increased the incidence of apoptosis in cumulus cells, affecting predominantly the middle and peripheral regions of the cumulus. The observed increase, however, had no effect on the developmental competence of the oocytes.


Assuntos
Apoptose/fisiologia , Fertilização in vitro/veterinária , Hormônio Foliculoestimulante/farmacologia , Glicoproteínas de Membrana/metabolismo , Oócitos/citologia , Receptor fas/metabolismo , Animais , Anticorpos/farmacologia , Apoptose/efeitos dos fármacos , Blastômeros/citologia , Caspase 3 , Caspases/metabolismo , Bovinos , Proteína Ligante Fas , Feminino , Atresia Folicular/fisiologia , Técnicas In Vitro , Glicoproteínas de Membrana/genética , Oócitos/efeitos dos fármacos , Oócitos/metabolismo , Ovário/citologia , RNA Mensageiro/análise , Transdução de Sinais/fisiologia , Receptor fas/genética , Receptor fas/imunologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA